2001 (8 POSTS)
Leazer TM, Rogers JM. 2001. Role of the acute phase response and tissue necrosis factor alpha in the developmental toxicity of lipopolysaccharide in the CD-1 mouse. Reprod Toxicol 16(2):173–179; doi: 10.1016/S0890-6238(02)00011-4 .
View Abstract
Publication: Manuscripts
Lea IA , Sivashanmugam P, O’Rand MG. 2001. Zonadhesin: Characterization, localization, and zona pellucida binding. Biol Reprod 65(6):1691–700; doi: 10.1095/biolreprod65.6.1691 .
View Abstract
Publication: Manuscripts
2000 (10 POSTS)
Shipp AM, Gentry PR, Lawrence G, Van Landingham C, Covington T , Clewell HJ, Gribben K, Crump K. 2000. Determination of a site-specific reference dose for methylmercury for fish-eating populations. Toxicol Ind Health 16(9-10):335–438.
View Abstract
Publication: Manuscripts
Andersen ME, Sarangapani R, Gentry PR, Clewell HJ, Covington TR , Frederick CB. 2000. Application of a hybrid CFD-PBPK nasal dosimetry model in an inhalation risk assessment: An example with acrylic acid. Toxicol Sci 57:312–325.
View Abstract
Publication: Manuscripts
Thompson CM , Capdevila JH, Strobel HW. 2000. Recombinant P450 2D18 metabolism of dopamine and arachidonic acid. J Pharmacol Exper Ther 294(3):1120–1130.
View Abstract
Publication: Manuscripts
Katona MA, Long TF, Kirman CR, Gargas ML, Rish WR . Derivation of a cancer potency factor and dermal absorption factor for benzo(a)pyrene. Toxicologist 54, Abstract 873. Presented at Society of Toxicology 39th Annual Meeting, Philadelphia, PA, March 2000.
Publication: Abstracts and Presentations
Jankowski-Hennig MA, Clegg MS, Daston GP, Rogers JM , Keen CL. 2000. Zinc-deficient rat embryos have increased caspase 3-like activity and apoptosis. Biochem Biophys Res Commun 271(1):250–256; doi: 10.1006/bbrc.2000.2608 .
View Abstract
Publication: Manuscripts
Lau C, Anderson ME, Crawford-Brown DJ, Kavlock RJ, Kimmel CA, Knudsen TB, Muneoka K, Rogers JM , Setzer RW, Smith G, Tyl R. 2000. Evaluation of biologically based dose-response modeling for developmental toxicity: A workshop report. Regul Toxicol Pharmacol 31(2):190–199; 10.1006/rtph.1999.1360 .
View Abstract
Publication: Manuscripts
Clewell HJ III, Gentry PR, Allen BC, Covington TR , Gearhart JM. 2000. Development of a physiologically-based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ Health Perspect 108(Suppl 2):283–305.
View Abstract
Publication: Manuscripts
Gentry R, Clewell H, Covington T , Wilson J. Investigation of the impact of Benchmark and PBPK modeling on the derivation of MRLs. Poster presented at the Society of Toxicology Annual Meeting, Philadelphia, PA, March 2000.
Publication: Abstracts and Presentations
Clewell HJ, Gentry PR, Gearhart JM, Born SL, Lehman-McKeeman LD, Covington TR . Development of a physiologically-based pharmacokinetic (PB-PK) model and human health risk assessment for coumarin. Poster presented at the Society of Toxicology Annual Meeting, Philadelphia, PA, March 2000.
Publication: Abstracts and Presentations
Choksi NY , Nix WB, Wyrick SD, Booth RG. 2000. A novel phenylaminotetralin (PAT) recognizes histamine H1 receptors and stimulates dopamine synthesis in vivo in rat brain. Brain Research 852(1):151–160; doi: 10.1016/s0006-8993(99)02228-3 .
View Abstract
Publication: Manuscripts
1999 (10 POSTS)
Choksi N Y , Nix WB, Wyrick SD, Booth RG. Phenylaminotetralins activate histamine H1 receptors to stimulate dopamine synthesis in vivo in rat brain. Poster presented at the Receptor Chemistry Towards the Third Millennium – 12th Camerino-Noordwijkerhout Symposium, 1999.
Publication: Abstracts and Presentations
Clewell HJ, Gearhart JM, Gentry PR, Covington TR , Van Landingham CB, Crump KS, and Shipp AM. 1999. Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokinetics. Risk Anal 19:541–552.
View Abstract
Publication: Manuscripts
Rish W , Kirman CR, Hays SM, Gargas ML, Andersen ME, Reitz RH, Guengerich FP, Green T, McConnell EE, Buckpit A, Voytek P, Dugard PH. 1999. Developing a physiologically based pharmacokinetic model to describe methylene chloride kinetics at the subcellular level. Toxicologist 48, Paper No. 671. Presented at Society of Toxicology 38th Annual Meeting, New Orleans, LA, March 1999.
Publication: Abstracts and Presentations
Zucker RM, Hunter ES III, Rogers JM . 1999. Apoptosis and morphology in mouse embryos by confocal laser scanning microscopy. Methods 18(4):473–480; doi: 10.1006/meth.1999.0815 .
View Abstract
Publication: Manuscripts
Parvathy S, Choksi N , Fang Y, Sabo SL, Buxbaum JD. Characterization of multipartite complexes of APP. Poster presented at Society for Neuroscience Annual Meeting, 1999
View Abstract
Publication: Abstracts and Presentations
Lilliehook C, Choksi NY , Hof P, Choi EK, Zaidi NF, Wasco W, et al. Characterization of the presenilin-binding protein calsenilin. Poster presented at Society for Neuroscience Annual Meeting, 1999
View Abstract
Publication: Abstracts and Presentations
Fang Y, Choksi NY , Parvathy S, Yamin JJ, Wasco W, Buxbaum JD. Proteins interacting with the COOH-termini of the presenilins. Poster presented at Society for Neuroscience Annual Meeting, 1999.
View Abstract
Publication: Abstracts and Presentations
Choksi NY , Mukherjeree P, Lindroth A, Xiang Z, Wasco W, Buxbaum JD, Pasinetti GM. Cyclooxygenase (COX)-2 expression is associated with presenilin-2 induced apoptosis. Poster presented at Society for Neuroscience Annual Meeting, 1999.